Mr. Adam Cegielski reports

EYECARROT CLOSES PRIVATE PLACEMENT

Eyecarrot Innovations Corp. has completed the previously announced non-brokered private placement for total proceeds of $1,260,800. The company issued a total of 8,405,332 units at a price of 15 cents per unit, each unit being composed of one common share and one common share purchase warrant, exercisable into one common share for a period of 24 months at an exercise price of 25 cents.

No finders' fees, brokers' fees or commissions were paid in connection with the offering.

All securities issued in connection with the private placement are subject to a four-month hold period expiring on April 3, 2017. Further restrictions may apply to certain subscribers under foreign securities laws.

Insiders participated in the private placement acquiring an aggregate of 932,667 shares on the same basis as other subscribers. The participation in the private placement by insiders of the company constitutes a related-party transaction as such term is defined under Multilateral Instrument 61-101 (protection of minority securityholders in special transactions). The company is relying on exemptions from the formal valuation and minority approval requirements under MI 61-101. The company relied on Section 5.5 (a) of MI 61-101 for an exemption from the formal valuation requirement and Section 5.7 (1) (a) of MI 61-101 for an exemption from the minority shareholder approval requirement of MI 61-101 as the fair market value of the transaction insofar as the transaction involved interested parties did not exceed 25 per cent of the company's market capitalization.

A material change report in connection with the private placement will be filed fewer than 21 days before the closing of the private placement. This shorter period is reasonable and necessary in the circumstances as the company wished to complete the private placement in a timely manner.

About Eyecarrot

Eyecarrot's goal is to power a global, data-driven, expert therapeutic network to transform how human oculomotor sensory performance is diagnosed, exercised and enhanced. The company is building Binovi, a universal, collaborative-care platform that integrates software, hardware, data, and the expert knowledge and insights of vision-care professionals to help patients on a global scale.

We seek Safe Harbor.